Migration patterns of dendritic cells in the mouse. Traffic from the blood, and T cell-dependent and -independent entry to lymphoid tissues by unknown
Lymphoid dendritic cells (DC)' (reviewed in references 1, 2) are critical
accessory cells for the induction of primary immune responses in vitro (e.g.,
references 3, 4) and in vivo. For example, administration of DC can trigger host
immune responses against antigens (5, 6), induce allograft rejection (7-9), and
reverse an Ir-gene defect (10). Donor-derived DC-like cells within nonlymphoid
organs could also be important "passenger" leukocytes that directly trigger
allograft rejection (7, 8), or host DC may present graft antigens (11). However
little is known ofthe traffic of DC into the tissues.
DC migrate from the tissues via afferent lymphatics as "veiled" cells (12). Some
of these cells draining the skin are presumably derived from Langerhans' cells
that develop into DC in culture (13). The finding of DC-like cells in most
nonlymphoid organs (14) suggests that a major- route for DC traffic is from the
peripheral tissues to the draining lymph nodes. DC are produced in the bone
marrow, but the precursors to DC and DC-like cells in the tissues have not yet
been identified. DC are present in peripheral blood (15) where they are similar
in phenotype and function to lymphoid DC isolated from spleen (16).
We have developed sensitive techniques to follow the traffic of small numbers
of highly purified DC. In this and in an accompanying paper (17) we report on
the migration of DC, particularly from the peripheral blood. Here we provide
evidence that a major migratory pathway of DC is via the blood circulation and
that the traffic ofDC into lymphoid tissues is regulated in part by T lymphocytes.
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Materials and Methods
C57BL/10 (C57, H-26), BALB/c (BALB, H-2d), DBA/2 (DBA, H-2d) and C3H/HeJ
(C3H, H-2') mice were from Olac Ltd., Bicester, Oxon, United Kingdom. Outbred and
inbred BALB nude mice were from Olac Ltd. or Sir William Dunn School of Pathology,
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University of Oxford, respectively. Male animals were recipients of cells prepared from
either sex.
Cell Preparation
Mice were killed in ether or by cervical dislocation. DC-enriched preparations and two
populations of purified DC were used in these studies.
Unsorted DC.
￿
DC were initially prepared from spleens as described (4). Briefly, DC
were obtained as low density (<1 .08) adherent cells (LODACS) from which many mac-
rophages were removed by readherence to tissue culture plates. These preparations were
routinely 70-85% DC enriched and contaminated by 5-10% lymphocytes and 5-15%
macrophages. The DC were then purified by two techniques (see below).
Sorted DC.
￿
LODACS were incubated at 4°C in the presence of 0.02% sodium azide
with saturating concentrations of rat mAbs against mouse macrophages (F4/80) (18), Lyt-
1 (53-7 .3) (19), Lyt-2 (CD8, 3 .155) (20), Fc receptors (2.4G2) (21), and Ig Kchains (187 .1)
(22), followed by FITC-rabbit anti-rat Ig (Dako Corp., Santa Barbara, CA). Purified DC
were obtained by negative selection using a Cytofluorograph System 50 (Ortho Diagnostic
Systems Inc., Westwood, MA) interfaced with a 2150 data handler (9); a three-parameter
sort was carried out, gating on forward and right angle scatter and fluorescence, at ^"3,500
cells/s. The viability and function ofthe sorted cells are discussed below, and in references
9 and 17. In other experiments, anti-complement receptor type 3 (anti-Mac-1, M1/70)
(23) was also included in the first antibody cocktail . Although DC weakly express this
molecule it was undetectable under these conditions.
On reanalysis, sorted DC were >99.5% negative for the markers used to remove
contaminating cells. They also did not bind mAbs directed against the T cell differentiation
antigens CD4 (L3T4) (24) and Thy-1 (25), or B cell markers (RA3-2C2/1 ; TIB145, and
RA3-3A1/6.1 ; TIB146) (26, 27). However in three separate experiments they were 88,
94, and 98% la-positive. Thus, sorted DC contained variable numbers of putative null
cells which are considered further in the Results.
EA- DC.
￿
As an alternative to cell sorting (above), Fc receptor-bearing cells (macro-
phages and some B cells) together with other lymphocytes were removed from LODACS
by rosetting with antibody-coated erythrocytes (EA) and a further density fractionation
(1). This approach was frequently more convenient than sorting, and the resultant cells
were >95% la'.
Other Cells.
￿
In some experiments DC were fixed in 0.1% glutaraldehyde for 10 min
at room temperature, and washed in serum-containing medium before use. T cells (>95%
pure) were derived from high-density (,1 .08) nylon-wool nonadherent spleen cells (1).
Cell Labeling and Transfer
A solution of "'In-chloride (Amersham Corp., Amersham U.K.; INS 1P; 370 mBq/ml,
sp act 1 .85 GBq/Ag) was diluted in saline to ^-125,000 cpm/,u1. Water-soluble carrier
tropolone (2-hydroxy-2-4-6-cycloheptatrien-l-on ; 4.4 mM in 20 mM Hepes-buffered
saline, pH 7.6; Fluorochem Ltd., Derbyshire, U.K.) was mixed in a 2:1 ratio (vol/vol) with
this solution for 15 s at 22 ° C. The mixture of "` In-tropolone was then added to cell
suspensions (15 A1/100 tal cells at 10'/ml; ^-1 juCi/106 cells) in RPMI 1640 medium
containing 5% FCS (Flow Laboratories, Rickmansworth, U.K.) and incubated for 5 min
at 22 °C (28). The cells were washed, resuspended in serum-free medium, and 2-5 X 105
cells were administered intravenously in 0.25 ml via the penile vein, or subcutaneously in
25 Al into each footpad of (ether-) anesthetized recipients. The labeling efficiency was
>65% for DC and >45% for T cells; cell viability was >90%, as determined by trypan
blue exclusion.
Cell Migration Studies
At various time intervals after cell transfer, the mice were killed by cervical dislocation
and exsanguinated. The following organs were removed in their entirety for direct
measurement of radioactivity in a well-type gamma counter: liver, spleen, lungs, mesen-
teric lymph nodes (MLN), peripheral lymph nodes (axillary, cervical, and brachial), Peyer's634
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patches, small intestine (gut), and both kidneys; a sample of skin with subcutaneous tissue
was also taken. Peripheral blood was collected and the radioactivity adjusted to cpm/ml
(1 ml is the approximate volume of blood per mouse). In addition, after subcutaneous
transfer, the activity of the hindfeet and popliteal, inguinal, and para-aortic lymph nodes
was measured; to facilitate identification of the nodes, ^-25 ul of 0.5% trypan blue (Flow
Laboratories) was injected subcutaneously at least 10 min before harvesting.
The activity in each tissue was expressed in two ways: (a) as a percentage of the total
radioactivity injected; and (b) as a percentage of the total radioactivity recovered per 0.1
g tissue sample (specific activity), which allows for the difference in size of the tissues and
the actual amount of label that is accessible.
Statistical Analysis
The significance of the differences between experimental groups were ascertained by
Student's t test.
Results
Experimental Design.
￿
In the first set of experiments the time course of migra-
tion of "iIn-labeled unsorted DC from the bloodinto lymphoid and nonlymphoid
compartments was established. In the second series, the traffic of sorted DC in
syngeneic, allogeneic, splenectomized, and nude recipients was studied. The
third series of experiments was designed to trace DC traffic via the afferent
lymphatics, after subcutaneous administration to the footpad. Control experi-
ments confirmed that DC function was not altered by radiolabeling (17). The
migration patterns of T cellsprocessed from the same spleens as DC were studied
for comparison.
Kinetics ofMigration of Unsorted DC and T Cellsfrom the Blood.
￿
Radiolabeled,
unsorted splenic DC (70-85% pure) were administered intravenously into syn-
geneic mice (Fig. 1). DC were sequestered primarily in the lungs until ^"1 h after
adoptive transfer, but the radioactivity declined exponentially to minimal levels
(<I%) by 24 h. At the same time there was a progressive increase in the numbers
of DC entering the liver and spleen, reaching plateau levels (---42% and ^"13%,
respectively) between 3 and 24 h. Thus, DC do not localize in these sites merely
by capillary trapping on their first pass through them . T lymphocytes were
initially retained in the lungs until ^-30 min andalso migrated to liver and spleen,
but in contrast to DC (p < 0.001), they reached plateau levels of ^-15% and
^-36%, respectively (Fig. 1).
30-50% of the radioactive label was spontaneously released from "'In-labeled
DC that were cultured in vitro over 24 h. Subsequent reutilization of the label
by freshly added DC was negligible (<5%). This, and the fact that only a minimal
amount of radioactivity was presentin the tissues afterintravenous administration
of an equivalent dose of cell-free '"In (Fig. 1, Table II legend), indicates that
the radioactivity detected in vivo reflects cellular migration from the blood and
is not due to reutilized isotope that was carried over or released from the cells.
Tissue Localization of Sorted DC.
￿
The migration of sorted DC in syngeneic
and allogeneic recipients was examined (Table 1) . Sorted DC, compared with
unsorted DC (Fig. 1, and not shown), showed an increased sequestration in the
liver (e .g., 57 .0% and 41 .6%, respectively, p < 0.001, for syngeneic strains at 24
h) but a decreased accumulation in the spleen (6 .9% and 13 .4%, p < 0.001).
Nevertheless, the spleen was again the principal site of DC localization in terms100,
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FIGURE 1 . Time course of
migration of unsorted dendri-
tic cells and T lymphocytes
from theblood into the lungs,
spleen, and liver of normal
mice. 4 X 105 DC (70-85%
pure) or T cells (>95% pure)
from spleens of BALB mice
were labeled with t "In-tropo-
lone and injected intrave-
nously into syngeneic recipi-
ents. The radioactivity in the
tissues at theindicated times is
expressed as a percentage of
the total dose injected. The
activity at 3 and 24 h after
injection of "'In alone is also
indicated. Means of three to
sevenexperiments areshown.
of specific activity. The migration of sorted DC to mesenteric and peripheral
lymph nodes, and to Peyer's patches was negligible (Table 1). In contrast, T
lymphocytes homed readily to these lymphoid tissues and relatively small num-
bers were retained in the liver (Table II). The differences in traffic between
sorted and unsorted DC could be explained by the removal of cells with the
migratory phenotype of T cells. In contrast to viable DC, glutaraldehyde-fixed
DC were preferentially trapped in the lungs of syngeneic recipients and their
numbers were reduced in liver and spleen (Table I, legend). The amount of
radiolabel in other tissues after intravenous transfer of viable DC was not
significantly above that after administration of glutaraldehyde-fixed DC (Table
I, and legend). Thus, DC can migrate from peripheral blood into some lymphoid
and nonlymphoid compartments, but unlike T cells they are unable to enter
lymph nodes.
The migration patterns were unaffected by histocompatibility barriers as only
trivial differences were observed between syngeneic and allogeneic recipients
(Table I). Nor did they represent the preferential return ofsplenic DC to their
site of origin since DC enriched from mesenteric lymph nodes (1) migrated
similarly(data not shown). The in vitro manipulation and purification procedures
did not appear to affect the traffic ofsorted DC, since the migration ofunsorted
DC that were preincubated under conditions used for labeling was similar to that
of untreated and unsorted DC (i.e., as for Fig. 1).
Despite sorting, some DC preparations contained la- cells (see Materials and
Methods). They did notcontribute to, oraffect the interpretation of, our results.
Firstly, when radiolabeled sorted DC were resorted for Ia+ cells and transferred,
the ratio of specific activities in the spleen and liver was 1.42, i.e., within the636
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TABLE I
Tissue Localization ofSorted Dendritic Cells
2-5 x 105 sorted DC (>99.5% pure) labeled with "' In-tropolone were injected intravenously into
syngeneicand allogeneic untreated mice. Lymphoid and nonlymphoid tissues were harvestedat 3
h and 24 h for measurement of radioactivity. The activity in each organ was expressed as a
percentage of the total dose injected, and as a percentage of the total label recovered per 0.1 g
tissue sample. Means ofthe indicated number of experiments (n) andp values betweenthe columns
arefootnoted. Blank spaces indicate values that are notsignificant. NA, notapplicable.
Syngeneicstrainswere: BALB, C57 and DBA; allogeneic combinations were BALB to C3H, C57
to DBA, and C57 to BALB. No significant differences were found between the individual strain
combinations within the groups of syngeneic or allogeneic recipients, so the results have been
combined.
The activity in peripheral lymph nodes (brachial, cervical, and axillary) was similar to that of
MLN (datanot shown).
When glutaraldehyde-fixed, "'In-tropolone-labeled DC were adoptively transferred into syn-
geneic recipients, the percentage of total radioactivity per organ at 3 and 24 h was, respectively:
liver, 8.3 and 18.49; spleen, 0.67 and 2.35; lungs, 23.94 and 5.67; MLN, 0.02 and 0.11; Peyer's,
0.03 and 0.06; gut, 1.02 and 2.67; skin, 3.62 and 4.59; kidney, 4.4 and 8.64;and blood, 2.4 and
0.56/ml; (n = 2). Most of the radioactivity in the blood was in the plasma rather than the cells,
after injection of viable or fixed cells.
* p < 0.05.
p < 0.01.
§ p< 0.001 .
range for sorted DC of 1.64 ± 0.27 (mean ± SD, the ratio for T cells being
25.73). Secondly, the resorted Ia- cells contained <10% of the expected radio-
label, precluding direct testing oftheir in vivo localization. They may be nonvi-
able cells that were killed or not completely removed by cell sorting.
Migration of DC in Splenectomized Mice.
￿
To exclude the possibility that small
numbers of DC could enter the lymph nodes from the blood but were undetect-
able by our techniques, we followed their traffic after splenectomy of the
recipients, a procedure that results in increased migration of lymphocytes to
lymph nodes (29). Unsorted DC were unable to enter the lymph nodes of
splenectomized mice (not shown), and the otherwise spleen-seeking DC were
quantitatively diverted to the liver (41 .6% and 53.0% in normal and splenecto-
Tissue
Radioactivity perorgan
(percent total dose injected)
Syngeneic Allogeneic
3h 24h 3h 24h
A B C D
Radioactivity per 0.1 g
(percent total label recovered)
Syngeneic Allogeneic
3h 24h 3h 24h
Liver 57.45 57.01 51 .73 54.79 7.42 7.39 6.75 7.04
Spleen 6.92 6.93 9.61 8.79 9.46 9.50 13.26 11 .93
Lungs 3.37* 0.30 4.86§ 0.55* 3.56 0.36 5.19 0.58
MLN 0.06 0.05 0.06 0.06 0.21 0.17 0.21 0.20
Peyer's 0.02 0.04 0.01 0.02 0.09 0.17 0.04 0.09
Gut 1.24 2.56§ 1.66§ 2.73 0.22 0.46 0.30 0.48
Skin 2.36 4.40 1.97§ 3.70 0.14 0.26 0.12 0.22
Kidney 3.42 2.96 4.98 5.86$ 1.38 1.20 2.04 2.36
Blood 0.87 0.46§ 0.76§ 0.38 NA NA NA NA
Total 75.71 74.76 75.64 76.88
n 3 3 4 4
p A/C A/B C/D B/DTotal
n
￿
6
￿
5
￿
5
￿
5
p A/C A/B C/D B/D
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TABLE 11
Tissue Localization ofTLymphocytes
Radioactivity perorgan
￿
Radioactivity per0.1 g
(percent totaldose injected)
￿
(percent total label recovered)
Tissue Syngeneic Allogeneic Syngeneic Allogeneic
Liver
Spleen
Lungs
MLN
Peyer's
Gut
Skin
Kidney
Blood
2-5 x 105 T cells labeled with ' 11In-tropolone were injected intravenously into syngeneic and
allogeneic mice. Lymphoid and nonlymphoid tissues were harvested 3 and 24 h later for measure-
ment of radioactivity. Fordetailssee Table I legend.
When cell-free " In was administered intravenously, the percentage of total radioactivity per
organ at 3 and 24 h wasrespectively: liver, 3.82 and 7.35; spleen, 0.45 and 1.77; lungs, 0.99 and
0.82; MLN, 0.06and 0.03; Peyer's, 0.02and 0.02; gut, 0.22 and 0.18; skin,0.64and 0.78;kidney,
1.1 and 1.52; and blood, 25.4 and 8.8/ml (n = 3 or 4).
*p< 0.05.
p< 0.01.
§p< 0.001 .
mized mice, respectively; n = 4, p < 0.01). In contrast, the migration of T cells
to MLN of splenectomized mice rose sharply (6.6% to 19.8%, p < 0.001), while
the increase in the liver was less dramatic (14.7% and 20 .5%, p < 0.01). Thus,
one of the distinctive features of DC is their inability to migrate from peripheral
blood into lymph nodes and hence to recirculate .
Migration ofDCfrom the Blood in Nude Mice.
￿
DC can form cell aggregates, or
clusters, with lymphocytes in culture in an MHC-independent manner (30). We
initially hypothesized that DC might enter the spleen through an analogous
interaction in vivo. Therefore we traced radiolabeled unsorted DC after intra-
venous injection in nude mice that lack mature T cells. At 24 h, the activity
within the spleens was greatly reduced to 3.2% (Table III); this value should be
compared with 13.4% in the spleens of euthymic mice and 2.4% for glutaralde-
hyde-fixed cells (Table 1, legend). Nude mice were then reconstituted with
syngeneic splenocytes or T cells 24 h before DC transfer. The numbers of DC
in the spleens of these animals now resembled those in the spleens of euthymic
mice (Table III). The numbers of DC entering the livers of nude mice were
inversely related to those migrating to the spleen (Table 111), as for splenecto-
mized hosts (see above). We conclude that migration of DC from the blood into
the spleen is dependent on the presence of T lymphocytes.
Migration of DC via Lymphatics.
￿
Having demonstrated that DC do not have
3h
A
24h
B
3h
C
24h
D 3h 24h 3h 24h
15.33* 14.71* 21 .40* 15.50 2.24 2.12 3.27 2.50
37.37$ 34.90 27.06 27.92* 57.63 53.27 43.68 47.57
1.56 0.84* 1.76§ 0.44* 1.86 0.99 2.20 0.58
4.21 6.60* 5.78 7.52 16.30 25.29 23.42 32.16
3.12 4.66* 2.78 3.55 15.13 22.37 14.12 19.02
0.55 0.75 0.36$ 0.68 0.11 0.15 0.08 0.15
1.46 1.98 1.34 1.76 0.10 0.13 0.09 0.13
1.74* 1.96 2.58 2.50 0.80 0.89 1.24 1.26
0.23 0.07§ 0.19§ 0.06 NA NA NA NA
65.57 65.97 63.25 59.9363 8
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TABLE III
Localization of Unsorted Dendritic Cells in Euthymic, Nude, and
Lymphocyte-reconstituted Nude Mice
Unsorted BALB DC were labeled with "' In-tropolone and injected intrave-
nously into euthymic recipients, nude mice, or nude mice reconstituted 24 h
earlier with 108 unfractionated splenocytes (SPL) or 4 X 107 Tcells. The liver,
spleen, and MLN were removed 24 h after injection and the activity in each
was measured. There were no differences between the resultsforoutbred and
inbred mice, and they have been combined. Means of the indicated number of
experiments (n) andpvalues between thegroups are shown.
* p< 0.001 .
sp < 0.01.
access to the lymph nodes from the blood, we followed their traffic via the
afferent lymphatics. Radiolabeled EA- DC (which migrate similarly to sorted DC
after intravenous transfer, data not shown) were administered subcutaneously
into the footpads of syngeneic mice. As shown in Table IV, a large amount of
activity was retained in the footpad until at least 24 h. However, some DC
migrated to thedrainingpopliteal lymph nodes asearlyas3 h afteradministration
and were present in relatively high numbers at 24 h. Virtually no activity was
detected in the inguinal lymph nodes, although a very small amount was found
in the para-aortic nodes. T lymphocytes also homed to the popliteal lymph nodes
after footpad injection, but at a slower rate compared with DC, and they were
retained here for at least 24 h (Table V). In contrast, only background radioac-
tivity was recorded in the popliteal lymph nodesafter injection ofglutaraldehyde-
fixed DC or cell-free isotope (Table V), or in the contralateral nodes when viable
DC were administered into one footpad (not shown). Thus, viable DC can enter
the draining lymph nodes from the peripheral tissues via the afferent lymphatics.
Since migration of DC from the blood into the spleen is dependent on the
presence ofTcells (Table III), we alsoexamined migration ofDC via the afferent
lymphatics in nude mice. There was no difference in the accumulation ofDC in
the popliteal lymph nodes between euthymic and nude mice (Table IV). There-
fore, migration of DC from the peripheral tissues into lymph nodes seems to be
independent of the presence ofT cells.
Discussion
We have examined the migration patterns ofsmall numbersofpurified splenic
DC in the mouse, using a technique that was based on the methods originally
described by Gowans and Knight (31) for studying the migration of mature rat
lymphocytes. 1"In-tropolone was used as a radiolabel since it seems to fulfill the
Radioactivity perorgan
(percent total dose injected)
Tissue
Euthymic
A
Nude
B
Nude + SPL
C
Nude + T
D
Liver 41 .57* 59.84* 41 .97 37.12
Spleen 13.42* 3.21* 9.35$ 10.60$
MLN 0.06 0.08 0.07 0.07
n 6 4 5 5
p A/B B/C A/C A/DKUPIEC-WEGLINSKI ET AL.
TABLE IV
Tissue Localization ofEA - Dendritic CellsAdministered into the Footpad ofEuthymic
and Nude Mice
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DC were prepared by EA rosetting, labeled with "'In-tropolone, and injected subcutaneously into
euthymic and nude mice. Forotherdetails see Materials and Methods and Table I legend.
* p < 0.05.
tp < 0.01.
§ p< 0.001 .
criteria proposed for the cell markers used for in vitro tracer studies (32). In
contrast to other isotopes, particularly sodium ("Cr) chromate to which DC are
particularly "leaky" (our unpublished observations), "'In-tropolone labels very
efficiently, attaches firmly to cytoplasmic components, is relatively nontoxic, and
is easily detectable in the organs. Furthermore, the cells can be processed in the
presence of serum (28), an advantage in DC preparation. The use of "'In-
tropolone prevents the formation of "`In-complexes with plasma transferrin,
which takes place when '"In-oxine is used (32).
Our results show that DC have a characteristic and distinctive migratory
phenotype. In particular, we have demonstrated a major migratory pathway for
DC from the blood, and T cell-dependent and -independent regulation ofentry
ofDC to lymphoid tissues.
Migration of DCfrom the Peripheral Blood.
￿
Although DC were initially seques-
tered in the lungs after adoptive transfer, they subsequently migrated into some
lymphoid and nonlymphoid compartments (Fig. 1). The primary site of DC
localization in termsofspecific activity inboth syngeneicand allogeneic recipients
was the spleen (Table I). This MHC-independent accumulation of splenic DC
was the same for MLN-derived DC, suggesting a real predilection ofDC for the
spleen rather than their return to the tissue oforigin .
Tissue
Radioactivity perorgan
(percent totaldose injected)
Euthymic Nude
3h 24h 3h 24h
A B C D
Radioactivity per 0.1 g
(percent total labelrecovered)
Euthymic Nude
3h 24h 3h 24h
Popliteal LN 0.65 1.18 1.78 1.02 57.95 141.43 86.6 125.9
Inguinal LN 0.05 0.01 0.05 0.01 2.21 0.34 0.67 0
Para-aortic LN 0.06 0.14 0.22 0.1 1.89 9.68 3.59 3.82
MLN 0.03 0.06 0.05 0.01 0.17 0.22 0.16 0
Peyer's 0.003 0.04 0.003 0.06 0.03 0.4 0 0.65
Gut 0.91 2.17* 0.75* 1.84 0.18 0.52 0.16 0.46
Liver 1.95 4.23# 2.33 5.7 0.4 0.91 0.38 1.45
Spleen 0.23 o.2 0.35 0.69$ 0.35 0.52 0.39 1.18
Lungs 0.32 0.3 0.33 0.42 0.38 0.42 0.37 0.56
Kidney 2.55 6.04§ 1.62* 5.06 1.76 4.59 1.13 4.27
Skin 2.45 3.4 1.2 2.73 0.27 0.4 0.17 0.61
Hind feet 44.31 27.44* 37.48* 24.89 26.9 18.35 25.43 22 .99
Blood 2.3 0.72 3.15 2.1 It NA NA NA NA
Total 55 .81 45.93 49.31 44.64
n 4 5 3 3
p A/C A/B C/D B/D640
￿
T DEPENDENCY OF DENDRITIC CELL MIGRATION FROM BLOOD
TABLE V
Tissue Localization ofTLymphocytes (T), Glutaraldehydefixed Dendritic Cells (gDC)and
Cellfree "'Indium ("'In) after Administration into the Foodpad
Fordetails see Materials and Methods and Table I legend.
* The values in parentheses represent the activity as a percentage of the total label recovered per
0.1 g of tissue.
A large number of DC migrated to the liver, the second major site of
sequestration in terms of specific activity (Table 1). T cells also migrated to the
spleen and liver, but the relative amount of activity in these sites was opposite to
that after transfer of DC (Table 11). Using techniques that are described in the
accompanying paper (17) to visualize the DC within frozen sections of liver,
many appeared to localize in the sinusoids. Although we cannot exclude the
possibility that at least some of these are dead or damaged cells, there are
precedentsfor normal cellular migration from the liver. Forexample, the hepatic
lymph has a higher flow rate and conveys a greater number oflymphocytes than
any other peripheral lymph in the sheep (33). Moreover, S. Fossum (personal
communication) using different techniques has shown that DC can migrate from
the blood to the liver and thence to the coeliac lymph nodes which we did not
examine.
The present studies suggest that an equilibrium exists between liver- and
spleen-seeking DC, akin to that between spleen- and lymph node-seeking T cells
(29). Thus, the number of DC entering the liver was inversely related to that
migrating to the spleen in nude and Tcell-reconstituted nude mice (Table 111),
and in splenectomized compared with normal mice. A similar equilibrium may
exist forspecifically sensitized T lymphocytes: after splenectomyofrats that were
rejecting cardiac allografts, sensitized splenocytes that would otherwise have
migrated to the spleen were sequestered in high numbers in the liver (34).
DC did not haveaccess to Peyer's patches and MLN or otherperipheral lymph
Tissue
3h
Radioactivity
T
24h
perorgan(percent total dose
gDC
3h 24h
injected)
"'In
3h 24h
Popliteal LN 0.23 0.78 0.06 0.12 0.11 0.12
(12.98)* (124.06) (5.61) (19.4) (9.0) (14.2)
Inguinal LN 0 0.02 0 0.02 0.02 0.03
Para-aortic LN 0.04 0.13 0 0.04 0.04 0.05
MLN 0.03 0.05 0.03 0.03 0.07 0.04
Peyer's 0.01 0.02 0.01 0.03 0.04 0.04
Gut 0.58 1.62 0.69 1.29 2.26 2.95
Liver 1.15 3.47 1.31 2.49 3.57 5.53
Spleen 0.1 0.22 0.11 0.14 0.29 0.34
Lungs 0.17 0.29 0.24 0.15 0.65 0.32
Kidney 1.97 6.09 2.47 3.67 7.04 6.35
Skin 1.8 2.35 2.44 2.66 5.2 5.26
Hind feet 69.43 28.77 33 .0 14.99 16.84 11 .63
Blood 1.42 0.67 2.26 0.31 4.91 0.44
Total 76.93 44.48 42.62 25 .94 41 .04 33.1
n 3 5 3 2 2 3KUPIEC-WEGLINSKI ET AL.
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nodes from the blood, even after splenectomy. Apparently, DC lack some cell
membrane constituent or receptor that would allow them to interact with the
postcapillary high endothelial venules. In contrast, Tcells homedreadilyto these
sites(Table 11) and there was increased entry into lymph nodes ofsplenectomized
mice. This is compatible with the demonstration of DC in the afferent but not
efferent or central lymph and is confirmatory evidence that, unlike T cells, DC
do not recirculate from blood to lymph. In this respect, DC behave similarly to
NK cells (35), peritoneal exudate macrophages (36), and splenic marginal zone
B cells (37), which are unable to contribute to the cellular recirculating pool.
The radioactivity in other tissues after intravenous administration of viable
DC was not detectably above control levels (Table I; compare legends to Tables
I and 11, and Tables IV and V). DC were rapidly cleared from the blood and the
small amount ofactivity present at later times was in plasma rather than the cells
(not shown); the levels in the kidney were probably related to the amount of
isotope being excreted. Although the activity in the gut and skin was higher
after transfer of DC than after T cells (compare Tables I and 11) this was not
above DC control levels. Either an undetectable number of DC entered these
sites, thought to be important for differentiation ofcells of the DC lineage, or
another precursor in blood (for which there is as yet no evidence) gives rise to
the Langerhans' cells and other DC-like cells ofnonlymphoidtissues. DC isolated
from peripheral blood ofhumans areindistinguishablein phenotypeand function
from those isolated from spleens and tonsils (15, 16). Presumably, they also exist
in the peripheral blood of rodents, but for practical reasons they cannot be
isolated. Perhaps this is the normal migratory and circulating form that is
produced by the bone marrow, i.e., DC may be released mature (like B cells)
rather than as immature precursors (like monocytes).
T Cell-dependent and -independent Migration ofDC to Lymphoid Tissues.
￿
When
the traffic of DC from the blood was examined in nude mice, we found they did
not enter the spleen (Table III). However, when the nude mice were reconsti-
tuted with T cells the levels of DC in the spleen now approached those in
euthymic mice . Thus migration of DC from the blood to the spleen is regulated
by T cells. Although we initially thought that this might be due to direct DC-T
cell clustering, analogous to that studied in vitro (30) and implicated in vivo (38),
elsewhere we present evidence that is contrary to this idea (17). In particular, we
have found that the DC are initially localized within the red pulp of the spleen
but that later, and only after a period of what appears to be active migration,
they enter the white pulp. Moreover, DC can bind to the marginal zone, perhaps
to the endothelium, and it seems likely that this interaction may be the one that
is controlled by the Tcells (17).
We also examined migration of DC via the afferent lymphatics. DC injected
SC into the footpadentered the drainingpopliteal lymph nodes (Table IV). Since
they did not have access to lymph nodes from the blood (Table 1), their sole
route of entry may be from afferent lymph. Other observations (39) that
macrophages became depleted from nodes that were surgically deprived oftheir
afferent lymph supply may be relevant in this context. Furthermore, at least
within 24 h, DC did not migrate beyond the local popliteal lymph nodes to the
inguinal nodes, an observation consistent with the absence ofDC in the efferent642
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lymph (12). There was no difference between euthymic and nude mice (Table
IV), showing that migration into the node is independent ofthe presence of T
cells.
That T cells can regulate the entry of DC into the spleen, but not lymph
nodes, may have a bearing on the migration pathways of DC from the blood into
nonlymphoid compartments. The present studies imply that DC, like cells ofthe
mononuclear phagocyte series, may exhibit both constitutive and T cell-regu-
lated migration into the tissues; monocytes, for instance, constitutively give rise
to tissue macrophages in the steady state, but can also be recruited into sites of
infection and inflammation (e.g., reference 40). We hypothesize that DC in blood
could be important for the generation of local immune responses at extralym-
phoid sites, and are currently investigating whether DC accumulate at sites of
inflammation and in organ allografts.
Summary
Dendritic cells (DC) are critical accessory cells for primary immune responses
and they may be important stimulators of transplantation reactions, but little is
known oftheir traffic into the tissues. We have studied the migration ofpurified
splenic DC and T lymphocytes, labeled with "'Indium-tropolone, in syngeneic
and allogeneic mice.
First we demonstrate that DC can migrate from the blood into some lymphoid
and nonlymphoid tissues. Immediately after intravenous administration, radio-
labeled DC were sequestered in the lungs, but they actively migrated into the
liver andspleen and reached equilibriumlevels between 3 and 24 hafter transfer.
At least half of the radiolabel accumulated in the liver, but the spleen was the
principal site of DC localization in terms ofspecific activity (radiolabel per weight
of tissue). DC were unable to enter Peyer's patches, or mesenteric and other
peripheral lymph nodes from the bloodstream. This was also true in splenecto-
mized recipients, where the otherwise spleen-seeking DC were quantitatively
diverted to the liver. In contrast, T cells homed readily to the spleen and lymph
nodes of normal mice and increased numbers were present in these tissues in
splenectomized mice. Thus, unlike T cells, DC cannot recirculate from blood to
lymph via the nodes.
We then showthat migration ofDCfrom the bloodinto thespleen is dependent
on the presence ofT cells: DC did not enter the spleens of nude mice, but when
they were reconstituted with T cells the numbers entering the spleen resembled
those in euthymic mice. In nude mice, as in splenectomized recipients, the DC
that would normally enter the spleen were quantitatively diverted to the liver.
These findings suggest that there is a spleen-liver equilibrium for DC, that may
be akin to that existing between spleen and lymph node for T cells.
Finally, we followed the traffic of radiolabeled DC via the afferent lymphatics
after subcutaneous footpad inoculation. DC accumulated in the popliteal nodes
but did not migrate further to the inguinal nodes. There was no difference
between euthymic and nude mice, showing that unlike traffic to the spleen, this
route probably does not require T cells. These migration patterns were not
affected by major histocompatibility barriers, and were only seen with viable,
but not glutaraldehyde-fixed, DC.KUPIEC-WEGLINSKI ET AL.
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The demonstration of a novel migratory pathway for DC from the blood,
together with T-dependent and -independent routes for entry to lymphoid
tissues, has important implications for the traffic of DC from the blood into
nonlymphoid tissues during inflammatory reactions and perhaps for the gener-
ation of extralymphoid immune responses.
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and Gordon MacPherson (Sir William Dunn School of Pathology, University of Oxford)
for helpful discussions.
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